No abstract available
MeSH terms
-
Antiviral Agents / pharmacology
-
Antiviral Agents / therapeutic use
-
Hepatitis B Surface Antigens
-
Hepatitis B virus / genetics
-
Hepatitis B* / drug therapy
-
Hepatitis B, Chronic* / drug therapy
-
Humans
-
Immune Checkpoint Inhibitors / therapeutic use
-
Risk Factors
-
Virus Activation
Substances
-
Antiviral Agents
-
Hepatitis B Surface Antigens
-
Immune Checkpoint Inhibitors